van Hooijdonk CA - Search Results

1

Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.

Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC. Smit JV, et al. Among authors: van hooijdonk ca. J Am Acad Dermatol. 2004 Aug;51(2):257-64. doi: 10.1016/j.jaad.2004.03.002. J Am Acad Dermatol. 2004. PMID: 15280845 Clinical Trial.

2

Adalimumab, a fully human anti-TNF-alpha monoclonal antibody, treatment does not influence experimental UV response in the skin of rheumatoid arthritis patients.

Tjioe M, Gerritsen MJ, Den Broeder AA, Van Hooijdonk CA, Kroot EJ, Van Riel PL, Barrera P, Van De Kerkhof PC. Tjioe M, et al. Among authors: van hooijdonk ca. Exp Dermatol. 2003 Aug;12(4):460-5. doi: 10.1034/j.1600-0625.2002.120414.x. Exp Dermatol. 2003. PMID: 12930303

3

Induction of ornithine decarboxylase following sellotape stripping in normal and psoriatic skin.

Arnold WP, van Hooijdonk CA, Mier PD, van de Kerkhof PC. Arnold WP, et al. Among authors: van hooijdonk ca, van de kerkhof pc. Br J Dermatol. 1990 Nov;123(5):581-5. doi: 10.1111/j.1365-2133.1990.tb01474.x. Br J Dermatol. 1990. PMID: 2248887

4

Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.

Glade CP, van Erp PE, van Hooijdonk CA, Elbers ME, van de Kerkhof PC. Glade CP, et al. Among authors: van hooijdonk ca, van de kerkhof pc, van erp pe. Acta Derm Venereol. 1995 Sep;75(5):381-5. doi: 10.2340/0001555575381385. Acta Derm Venereol. 1995. PMID: 8615058 Free article. Clinical Trial.

5

The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).

van Pelt JP, de Jong EM, van Erp PE, Mitchell MI, Marder P, Spaethe SM, van Hooijdonk CA, Kuijpers AL, van de Kerkhof PC. van Pelt JP, et al. Among authors: van hooijdonk ca, van de kerkhof pc, van erp pe. Biochem Pharmacol. 1997 Apr 4;53(7):1005-12. doi: 10.1016/s0006-2952(96)00884-2. Biochem Pharmacol. 1997. PMID: 9174114 Free article. Clinical Trial.

6

Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.

Van Pelt JP, De Jong EM, Seijger MM, Van Hooijdonk CA, De Bakker ES, Van Vlijmen IM, Parker GL, Van Erp PE, Van De Kerkhof PC. Van Pelt JP, et al. Among authors: van hooijdonk ca. Br J Dermatol. 1998 Sep;139(3):396-402. doi: 10.1046/j.1365-2133.1998.02401.x. Br J Dermatol. 1998. PMID: 9767282 Clinical Trial.

7

The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.

Mommers JM, Castelijns FA, Seegers BA, Van Rossum MM, Van Hooijdonk CA, Van Erp PE, Van De Kerkhof PC. Mommers JM, et al. Among authors: van hooijdonk ca. Br J Dermatol. 1998 Sep;139(3):468-71. doi: 10.1046/j.1365-2133.1998.02411.x. Br J Dermatol. 1998. PMID: 9767292 Clinical Trial.

8

Quantification of epidermal cell populations in the centre and margin of stable psoriatic plaques.

Mommers JM, van Rossum MM, van Hooijdonk CA, van Erp PE, van de Kerkhof PC. Mommers JM, et al. Among authors: van hooijdonk ca. Arch Dermatol Res. 1999 Feb-Mar;291(2-3):88-92. doi: 10.1007/s004030050388. Arch Dermatol Res. 1999. PMID: 10195395

9

Multi parameter flow cytometric assessment of regenerative epidermis with special reference to the antiproliferative effect of occlusion.

van Rossum MM, Mommers JM, van de Kerkhof PC, de Jongh GJ, van Hooijdonk CA, van Erp PE. van Rossum MM, et al. Among authors: van hooijdonk ca. Anal Cell Pathol. 1998;17(3):157-65. doi: 10.1155/1998/245275. Anal Cell Pathol. 1998. PMID: 10221330 Free PMC article.

10

The response of distant uninvolved psoriatic skin to standardised injury is not different from that in normal skin.

van Rossum MM, Mommers JM, van Hooijdonk CA, van Erp PE, van de Kerkhof PC. van Rossum MM, et al. Among authors: van hooijdonk ca. Skin Pharmacol Appl Skin Physiol. 1999 Sep-Oct;12(5):271-5. doi: 10.1159/000066252. Skin Pharmacol Appl Skin Physiol. 1999. PMID: 10461096 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters